Article Text
Abstract
Objective Regarding the use of lung ultrasound (LU) in neonatal intensive care units (NICUs) across Europe, to assess how widely it is used, for what indications and how its implementation might be improved.
Design and intervention International online survey.
Results Replies were received from 560 NICUs in 24 countries between January and May 2023. LU uptake varied considerably (20%–98% of NICUs) between countries. In 428 units (76%), LU was used for clinical indications, while 34 units (6%) only used it for research purposes. One-third of units had <2 years of experience, and only 71 units (13%) had >5 years of experience. LU was mainly performed by neonatologists. LU was most frequently used to diagnose respiratory diseases (68%), to evaluate an infant experiencing acute clinical deterioration (53%) and to guide surfactant treatment (39%). The main pathologies diagnosed by LU were pleural effusion, pneumothorax, transient tachypnoea of the newborn and respiratory distress syndrome. The main barriers for implementation were lack of experience with technical aspects and/or image interpretation. Most units indicated that specific courses and an international guideline on neonatal LU could promote uptake of this technique.
Conclusions Although LU has been adopted in neonatal care in most European countries, the uptake is highly variable. The main indications are diagnosis of lung disease, evaluation of acute clinical deterioration and guidance of surfactant. Implementation may be improved by developing courses and publishing an international guideline.
- neonatology
- intensive care units, neonatal
- respiratory medicine
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
X @AlmudenaAlonso4, @ClausKlingenbe1
Collaborators ESPR Pulmonary Research Consortium: Kajsa Bohlin: Department of Neonatology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden. Theodore Dassios: University of Patras, Greece. Daniele De Luca: Division of Pediatrics and Neonatal Critical Care, 'A.Béclère' Medical Center, Paris, Saclay University Hospitals, APHP, Paris, France Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris-Saclay University, Paris, France. Roland Hentschel: Center for Pediatrics, Department of Neonatology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Rania Kaltsogianni: Department of Women and Children’s Health, King’s College London, London, UK. Gianluca Lista: Department of Neonatology, V. Buzzi Children’s Hospital, ASST-FBF-Sacco, Milan, Italy. Timo Saarela: Department of Pediatrics and Adolescent Medicine, University Hospital of Oulu and Oulu University, Oulu, Finland. Ulrich Thome: Facharzt für Kinder- und Jugendmedizin/Neonatologie/Pädiatrische Intensivmedizin, Universitätsklinik für Kinder- und Jugendmedizin, Zentrum für Frauen- und Kindermedizin, Leipzig, Germany. Tobias Werther: Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Austria. Mirko Zibolen: Clinic of Neonatology, Jessenius Faculty of Medicine and University Hospital Martin, Slovakia.
Contributors AA-O conceptualised and designed the study, designed the data collection instruments, carried out the initial analysis and wrote the first draft. She is guarantor. AHvK designed data collection tools, analysed the data and drafted and revised the paper. AA-O, AHvK, HE, MC, AL, TS, VS, GR, RS, MW, CH, HS, OD, CCR, MC, AC, GD, BB, CK, SS, RP, RT, CPFO'D implemented the survey in their countries, collected data and critically reviewed the draft paper.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.